BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29162948)

  • 21. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
    Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
    Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.
    Bonadio I; Colle I; Geerts A; Smeets P; Berardi G; Praet M; Rogiers X; de Hemptinne B; Van Vlierberghe H; Troisi RI
    Clin Transplant; 2015 May; 29(5):425-33. PubMed ID: 25808782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
    Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
    Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
    Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.
    Guerrini GP; Pinelli D; Di Benedetto F; Marini E; Corno V; Guizzetti M; Aluffi A; Zambelli M; Fagiuoli S; Lucà MG; Lucianetti A; Colledan M
    Surg Oncol; 2016 Dec; 25(4):419-428. PubMed ID: 26403621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
    Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation.
    Li H; Wang S; Wang G; Zhang Z; Wu X; Zhang T; Fu B; Chen G
    Dig Surg; 2014; 31(6):468-78. PubMed ID: 25632982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
    Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation.
    Wu L; Xu X; Shen J; Xie H; Yu S; Liang T; Wang W; Shen Y; Zhang M; Zheng S
    J Surg Oncol; 2007 Jul; 96(1):62-8. PubMed ID: 17443726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Guerrini GP; Pinelli D; Marini E; Corno V; Guizzetti M; Zambelli M; Aluffi A; Lincini L; Fagiuoli S; Lucianetti A; Colledan M
    Prog Transplant; 2018 Mar; 28(1):63-69. PubMed ID: 29251164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.
    Xiao GQ; Liu C; Liu DL; Yang JY; Yan LN
    World J Gastroenterol; 2013 Dec; 19(45):8398-407. PubMed ID: 24363533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.
    Zhang Q; Chen X; Zhou J; Zhang L; Zhao Q; Chen G; Xu J; Qian F; Chen Z
    Cancer Biol Ther; 2006 Jul; 5(7):808-14. PubMed ID: 16775432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver.
    Chen HY; Han ZB; Fan JW; Xia J; Wu JY; Qiu GQ; Tang HM; Peng ZH
    Med Oncol; 2012 Sep; 29(3):1859-65. PubMed ID: 21786180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.
    Hu J; Wang Z; Fan J; Dai Z; He YF; Qiu SJ; Huang XW; Sun J; Xiao YS; Song K; Shi YH; Sun QM; Yang XR; Shi GM; Yu L; Yang GH; Ding ZB; Gao Q; Tang ZY; Zhou J
    PLoS One; 2011; 6(10):e26003. PubMed ID: 21998744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma.
    Heits N; Brosch M; Herrmann A; Behrens R; Röcken C; Schrem H; Kaltenborn A; Klempnauer J; Kreipe HH; Reichert B; Lenschow C; Wilms C; Vogel T; Wolters H; Wardelmann E; Seehofer D; Buch S; Zeissig S; Pannach S; Raschzok N; Dietel M; von Schoenfels W; Hinz S; Teufel A; Evert M; Franke A; Becker T; Braun F; Hampe J; Schafmayer C
    Transplantation; 2018 Oct; 102(10):e424-e430. PubMed ID: 29994984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single nucleotide polymorphism in the vascular endothelial growth factor gene is associated with recurrence of hepatocellular carcinoma after transplantation.
    Wu LM; Xie HY; Zhou L; Yang Z; Zhang F; Zheng SS
    Arch Med Res; 2009 Oct; 40(7):565-70. PubMed ID: 20082870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.
    Macdonald B; Sewell JL; Harper AM; Roberts JP; Yao FY
    Clin Transplant; 2015 Jun; 29(6):506-12. PubMed ID: 25777321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
    Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
    Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.